Table of Contents

1 Study Coverage

• 1.1 Pediatric Medicines Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Pediatric Medicines Market Size Growth Rate by Product
  • 1.4.2 Enteral
  • 1.4.3 Parenteral
  • 1.4.4 Topical
• 1.5 Market by End User
  • 1.5.1 Global Pediatric Medicines Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Family
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pediatric Medicines Market Size
  • 2.1.1 Global Pediatric Medicines Revenue 2014-2025
  • 2.1.2 Global Pediatric Medicines Sales 2014-2025
• 2.2 Pediatric Medicines Growth Rate by Regions
  • 2.2.1 Global Pediatric Medicines Sales by Regions
  • 2.2.2 Global Pediatric Medicines Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Pediatric Medicines Sales by Manufacturers
  • 3.1.1 Pediatric Medicines Sales by Manufacturers
  • 3.1.2 Pediatric Medicines Sales Market Share by Manufacturers
  • 3.1.3 Global Pediatric Medicines Market Concentration Ratio (CR5 and HHI)
• 3.2 Pediatric Medicines Revenue by Manufacturers
  • 3.2.1 Pediatric Medicines Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pediatric Medicines Revenue Share by Manufacturers (2014-2019)
• 3.3 Pediatric Medicines Price by Manufacturers
• 3.4 Pediatric Medicines Manufacturing Base Distribution, Product Types
  • 3.4.1 Pediatric Medicines Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pediatric Medicines Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pediatric Medicines Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Pediatric Medicines Sales by Product
• 4.2 Global Pediatric Medicines Revenue by Product
• 4.3 Pediatric Medicines Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Pediatric Medicines Breakdown Data by End User

6 North America

• 6.1 North America Pediatric Medicines by Countries
  • 6.1.1 North America Pediatric Medicines Sales by Countries
  • 6.1.2 North America Pediatric Medicines Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Pediatric Medicines by Product
• 6.3 North America Pediatric Medicines by End User

7 Europe

• 7.1 Europe Pediatric Medicines by Countries
  • 7.1.1 Europe Pediatric Medicines Sales by Countries
  • 7.1.2 Europe Pediatric Medicines Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pediatric Medicines by Product
• 7.3 Europe Pediatric Medicines by End User

8 Asia Pacific

• 8.1 Asia Pacific Pediatric Medicines by Countries
  • 8.1.1 Asia Pacific Pediatric Medicines Sales by Countries
  • 8.1.2 Asia Pacific Pediatric Medicines Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Pediatric Medicines by Product
• 8.3 Asia Pacific Pediatric Medicines by End User

9 Central & South America

• 9.1 Central & South America Pediatric Medicines by Countries
  • 9.1.1 Central & South America Pediatric Medicines Sales by Countries
  • 9.1.2 Central & South America Pediatric Medicines Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Pediatric Medicines by Product
• 9.3 Central & South America Pediatric Medicines by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Pediatric Medicines by Countries
  • 10.1.1 Middle East and Africa Pediatric Medicines Sales by Countries
  • 10.1.2 Middle East and Africa Pediatric Medicines Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Pediatric Medicines by Product
• 10.3 Middle East and Africa Pediatric Medicines by End User

11 Company Profiles

• 11.1 GSK
  • 11.1.1 GSK Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 GSK Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 GSK Pediatric Medicines Products Offered
  • 11.1.5 GSK Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novartis Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novartis Pediatric Medicines Products Offered
  • 11.2.5 Novartis Recent Development
• 11.3 Pfizer
  • 11.3.1 Pfizer Company Details
  • 11.3.2 Company Business Overview
• 11.3.Pfizer Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Pfizer Pediatric Medicines Products Offered
  • 11.3.5 Pfizer Recent Development
• 11.4 Sanofi
  • 11.4.1 Sanofi Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Sanofi Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Sanofi Pediatric Medicines Products Offered
  • 11.4.5 Sanofi Recent Development
• 11.5 Abbott
  • 11.5.1 Abbott Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Abbott Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Abbott Pediatric Medicines Products Offered
  • 11.5.5 Abbott Recent Development
• 11.6 Bristol-Myers Squibb
  • 11.6.1 Bristol-Myers Squibb Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Bristol-Myers Squibb Pediatric Medicines Products Offered
  • 11.6.5 Bristol-Myers Squibb Recent Development
• 11.7 Cipla
  • 11.7.1 Cipla Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Cipla Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Cipla Pediatric Medicines Products Offered
  • 11.7.5 Cipla Recent Development
• 11.8 Eisai Pharmaceuticals
  • 11.8.1 Eisai Pharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Eisai Pharmaceuticals Pediatric Medicines Products Offered
  • 11.8.5 Eisai Pharmaceuticals Recent Development
• 11.9 Eli Lilly
  • 11.9.1 Eli Lilly Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Eli Lilly Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Eli Lilly Pediatric Medicines Products Offered
  • 11.9.5 Eli Lilly Recent Development
• 11.10 F. Hoffman-La Roche
  • 11.10.1 F. Hoffman-La Roche Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 F. Hoffman-La Roche Pediatric Medicines Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 F. Hoffman-La Roche Pediatric Medicines Products Offered
  • 11.10.5 F. Hoffman-La Roche Recent Development
• 11.11 Glenmark
• 11.12 Helsinn Healthcare
• 11.13 Heron Therapeutics
• 11.14 Ipca Laboratories

12 Future Forecast

• 12.1 Pediatric Medicines Market Forecast by Regions
  • 12.1.1 Global Pediatric Medicines Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Pediatric Medicines Revenue Forecast by Regions 2019-2025
• 12.2 Pediatric Medicines Market Forecast by Product
  • 12.2.1 Global Pediatric Medicines Sales Forecast by Product 2019-2025
  • 12.2.2 Global Pediatric Medicines Revenue Forecast by Product 2019-2025
• 12.3 Pediatric Medicines Market Forecast by End User
• 12.4 North America Pediatric Medicines Forecast
• 12.5 Europe Pediatric Medicines Forecast
• 12.6 Asia Pacific Pediatric Medicines Forecast
• 12.7 Central & South America Pediatric Medicines Forecast
• 12.8 Middle East and Africa Pediatric Medicines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pediatric Medicines Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The pediatric drug market plays a pivotal role in the pharmaceutical industry.
The pediatric medicines market identifies the formulatory advancement as one of the primary factors for this market’s growth.
The global Pediatric Medicines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pediatric Medicines market based on company, product type, end user and key regions.

This report studies the global market size of Pediatric Medicines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pediatric Medicines in these regions.
This research report categorizes the global Pediatric Medicines market by top players/brands, region, type and end user. This report also studies the global Pediatric Medicines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories

Market size by Product
Enteral
Parenteral
Topical
Market size by End User
Hospital
Clinic
Family

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pediatric Medicines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pediatric Medicines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pediatric Medicines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pediatric Medicines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pediatric Medicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pediatric Medicines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.